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CO-INFECTION BETWEEN INFLUENZA VIRUS AND FLAGELLATED BACTERIA
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SUMMARY
Trypsin is required in the hemagglutinin (HA) cleavage to in vitro influenza viruses activation. This HA cleavage is necessary
for virus cell entry by receptor-mediated endocytosis. Bacteria in the respiratory tract are potential sources of proteases that could
contribute to the cleavage of influenza virus in vivo. From 47 samples collected from horses, pigs, and from humans, influenza
presence was confirmed in 13 and these samples demonstrated co-infection of influenza with flagellated bacteria, Stenotrophomonas
maltophilia from the beginning of the experiments. Despite treatment with antibiotics, the bacteria remained resistant in several of
the co-infected samples (48.39%). These bacteria, considered opportunistic invaders from environmental sources, are associated
with viral infections in upper respiratory tract of hosts. The protease (elastase), secreted by Stenotrophomonas maltophilia plays
a role in the potentiation of influenza virus infection. Proteolytic activity was detected by casein agar test. Positive samples from
animals and humans had either a potentiated influenza infectivity or cytopathic effect (CPE) in MDCK and NCI H292 cells,
Stenotrophomonas maltophilia were always present. Virus and bacteria were observed ultrastructurally. These in vitro findings
show that microbial proteases could contribute to respiratory complications by host protease activity increasing inflammation or
destroying endogenous cell protease inhibitors.
KEYWORDS: Stenotrophomonas maltophilia; Influenza virus; Co-infections in vitro.
INTRODUCTION
Influenza virus is the most important cause of viral pneumonia in
adults, nevertheless there is also concern regarding pulmonary infection
due to adenovirus21.
An interaction between bacteria and influenza A virus during the
development of influenza pneumonia has been reported in several
studies investigating the role of bacterial proteases on the influenza
hemagglutinin cleavage1,3,16,17,25,28.
Cleavage of the influenza A virus hemagglutinin (HA) is required
for the virus cell entry mediated by endocytosis receptor8. Cleavage of
the intact HA0 into HA1 and HA2, allows exposure of the amino
terminal fusion peptide of the cleavaged HA in viral pathogenicity and
tissue tropism11. Previous studies have clearly demonstrated the
requirement for trypsin in activation by cleavage of influenza A viruses
in vitro7,9,12.
Bacteria present in the respiratory tract are potential sources of
proteases that could contribute to cleavage influenza virus in vivo.
Susceptibility of HA to cleavage by host intracellular proteases is the
major factor distinguishing highly virulent avian influenza viruses from
avirulent avian and mammalian viruses. Since HAs of avirulent avian
viruses contain the multiple basic amino acid sequence R-X-K/R-R,
these viruses are susceptible to host intracellular proteases, such as
furin and PC6 that can activate this avirulent strain5,23,27.
A protease in allantoic fluid, similar to the mammalian blood
clotting factor X, was demonstrated to activate influenza virus grown
in embryonated chicken eggs, and to determine the specific tissue
tropism4,13. The tryptase Clara, a trypsin-like protease produced by the
rat bronchiolar Clara cell, is secreted into the rat respiratory tract and
is capable of cleavage activation of influenza viruses. Similar proteases,
however, have not been demonstrated in other mammalian species.
Thus, this matter is not yet conclusively determined6.
The most probable potential sources of proteases, in vivo, which
may contribute to influenza virus cleavage activation are produced by
some strains of Streptomyces griseus, Staphylococcus aureus and
Streptococcus pyogenes, isolated from human and animal respiratory
tracts. Streptokinase and staphylokinase can facilitate cleavage
activation by generation of plasmin from plasminogen13,20,26.
It is believed that microbial proteases can potentiate the cleavage
activation of influenza virus by mechanisms other than direct cleavage
of the HA. Studies with staphylokinase, streptokinase and other
bacterial proteases indicate that they potentiate cleavage activation by
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activating host proteases such as kallikrein, plasmin or thrombin. This
could increase inflammation or destroy endogenous protease
inhibitors17.
Pseudomonas aerugynosa combined with influenza virus has
demonstrated enhanced virus titers and pathogenicity in mice17. These
microorganisms may be opportunist commensals of the human or
animal upper respiratory tracts. In contrast, Stenotrophomonas
maltophilia are most likely to be opportunistic invaders from
environmental sources2.
This study evaluated in vitro the co-infection between
Stenotrophomonas maltophilia and influenza virus in samples isolated
from animals, such as pigs and horses, as well as humans in close
proximity with these animals due to their profession. The clinical
manifestations of the classical Flu syndrome were not targeted, thereby
also taking into account the occurrence of influenza in subclinical
infections14,19.
MATERIAL AND METHODS
1. Subjects: A total of 47 individuals (24 swines, 11 equines and
12 humans) were studied. No clinical manifestations of influenza illness
were observed in these subjects during collection of the samples. The
subjects were housed or worked indoors at locations a, b, c with
commercial production facilities. Location b was managed in
accordance with the rules of good hygiene practices for animal
husbandry, while the other locations did not meet these standards24.
2. Samples: Material from both the animals and humans were
collected with oral-tracheal swabs. These samples were treated in
transport medium Eagle pH 7.2-7.4, with the addition of 1% bovine
albumin, 2,000 U/mL penicillin G, 2.5 mg/mL streptomycin and
25 µL/mL fungizone. The samples were maintained at 2 - 8 °C overnight
and then the tests were performed3.
3. Virus isolation and characterization
a. Chicken embryonated eggs: 0.2 mL of the sample were
inoculated into allantoic cavities of 10-day-old chick embryos, using
three eggs from Leghorn ”specific pathogen free” (spf) chicken for
each sample. The inoculated eggs were incubated at 33 0C for seven
days and then infected fluid was harvested and assayed by HA test,
with rooster red blood cells suspension at 0.5%. Samples were
considered negative when they did not present the hemagglutinin after
three passages in eggs9.
b. Cell culture: 0.2 mL of the sample were used to inoculate two
types of tissue cultures: MDCK(canine)(ATCC-CCL34) and NCI
H292(human)(ATCC-CC1848) with added trypsin (0.2 µg/mL). Both
of the cell cultures were incubated at 33 0C for seven days. The
inoculated samples were observed for three passages and, if no
cytopathic effect was detected seven days after the inoculation and
hemagglutinin in both cellular systems, these samples were considered
negative for the presence of the virus9.
c. Hemagglutination test: Hemagglutination titers were
determined at room temperature in a microtiter system. Serial two-
fold dilutions of virus (25 µL) in phosphate buffered pH 7.2 were mixed
with 25 µL of a 0.5% suspension from rooster red blood cells.
Hemagglutination titers were determined after one h, unless otherwise
started, and are expressed as the reciprocal of the maximum dilution
of virus that caused complete agglutination10.
d. Influenza A/B Rapid Test (by ROCHE Kit Insert): The test
principle is based on the Roche diagnostics: GLORIA (gold-labeled-
optically-read-immunoassay). The viral nucleoprotein and viral nucleic
acid that are released by lysing the influenza virus envelope with Lysis/
Elution Solution are detected. The test uses two pairs of monoclonal
antibodies to specific influenza A and other specific influenza B. Both
antibody pairs are conjugated to either biotin and digoxigenin. In the
presence of the viral antigen, a sandwich complex is formed, consisting
of the biotin-conjugated antibody, the nucleoprotein, and the
digoxigenin- conjugated antibody. When the test strip is placed in the
reaction cup, the complex migrates chromatographically, solubilizing
colloidal gold particles incorporated in the red pad of the strip. The
colloidal gold particles bind to the digoxigenin of the complex, which
is then bound by the biotin to the immobilized streptavidin on the strip
(positive result line). Any excess gold particles continue to migrate to
the second line (control line), which then becomes visible. This indicates
the correct chromatographic migration. According to the information
in the Influenza A/B Rapid Test Kit, no cross reactivity occurs with
other probable respiratory viruses or other organisms, such as bacteria
or fungi.
4. Bacterial isolates: Samples collected from the subjects
presenting bacterial contamination, during viral replication, were
submitted to bacterial isolation after three material passages into the
medium Tryptic Soy Broth (TSB) at 25 - 33 °C for 48 h. Then, samples
were collected for bacteria characterization3. The Clinical Laboratory
of Pharmaceutical Science Faculty of São Paulo University, SP, Brazil,
performed the bacteria characterization.
5. Proteolytic activity of the bacterial culture fluid: Stored
bacterial isolates were cultured in Tryptic Soy Broth (TSB) and these
cultures were centrifuged at 12,000 g for 15 min at 4 °C and filtered
through a Millipore 0.45 µm pore-diameter syringe filter. This clarified
supernatant was tested for proteolytic activity on casein agar plates.
The casein agar plates consisting of 25 mM Tris (pH 7.2), 150 mM
NaCl, 0.6% casein (Sigma technical grade) and 1% Bacto Agar (Difco).
Aliquots (10 µL) of culture supernatants were placed in 3 mm diameter
wells cut in the casein agar and incubated at 37 °C for 18 h. The plates
were overlaid with 3% acetic acid, and proteolytic activity was noted
as a zone of clearing around the sample well. Trypsin (1 µg/mL) was
used as a positive control standard3.
Caseinolytic activity, relative to trypsin, was determined by
measuring the diameter of the proteolytic zones around each well.
6. Electron microscopy: Negative Staining - This is a direct
application method for electron microscopy. A digital pipette was used
to place a drop (10 µL) of viral suspension on the collodion-carbon-
coated surface of a copper grid. Excess fluid was removed with filter
paper, and a drop (10 µL) of negative stain (PTA) was added. Excess
fluid was removed with filter paper. Then, the grid was air dried
overnight, examined on the electron microscope Zeiss 109, operated
at 80 kV, and the microorganism particles were photographed10.




The data presented (Tables 1, 2 and 3) for all the tests or single test
demonstrate the presence of the influenza virus in samples isolated
from pigs, humans and horses and co-infection with Stenotrophomonas
maltophilia. The samples isolated from pigs and humans from locations
a and c (Tables 1 and 2) were confirmed influenza positive by the
Influenza AB Rapid Test, after screening by CPE and HA tests. The
sample isolated from pig No. 01 was positive in the first passage in
cells and became negative after the third passage, but still egg positive.
Of the pig samples tested with casein agar, four grown in eggs and five
grown in cell cultures were positive for bacterial co-infection with
influenza. Using the same test, the human samples demonstrated five
positives, one harvested from egg and four from cell culture systems
(Fig. 2). These samples presenting bacterial co-infection, induced
intense CPE into the 72 h in cell cultures such as MDCK and NCI.
Data obtained from pig and human samples, from Location b, were
influenza positives, presented cytopathic effect in MDCK cells, and
had not co-infected with bacteria. Regarding the samples collected
from horses, belonging to Location c (Table 3), grown in eggs as well
as in cell cultures (MDCK and NCI) demonstrated CPE and HA
positives. These samples were identified and characterized as Influenza
Table 1
Swine influenza identification/characterization and co-infection with flagellated bacteria
Cell culture Identification/ Casein agar bacterial
Samples Egg MDCK NCI Characterization protease test
Location HA CPE HA CPE HA RT A/B Egg Cell
1 a P P N N N NT NT NT
2 a P P P P P P P P
3 a P N N P P P N P
4 a P N P P N P P P
5 a P N P P P P P P
6 a N P P N P P P P
7 a N N P P P N N NT
P = positive; N = negative; NT = Not Tested; CPE = cytopathic effect; HA = hemagglutination test; RT = Influenza A/B Rapid Test (ROCHE Lab.).
Table 2
Human influenza identification/characterization and co-infection with flagellated bacteria
Cell culture Identification/ Casein agar bacterial
Samples Egg MDCK NCI Characterization protease test
Location HA CPE HA CPE HA RT A/B Egg Cell
1 a P P P P P P N P
2 a N N N N N NT P N
3 a P P N P P P NT P
4 a P P P P P P N P
5 c P P P P N P N P
P = positive; N = negative; NT = Not Tested; CPE = cytopathic effect; HA = hemagglutination test; RT = Influenza A/B Rapid Test (ROCHE Lab.).
Table 3
Equine influenza identification/characterization and co-infection with flagellated bacteria
Cell culture Identification/ Casein agar bacterial
Samples Egg MDCK NCI Characterization protease test
Location HA CPE HA CPE HA RT A/B Egg Cell
1 C P P P P P P P P
2 C P P P N N P P P
3 C P P P N N P P P
4 C P P P P P P P P
P = positive; N = negative; NT = Not Tested; CPE = cytopathic effect; HA = hemagglutination test; RT = Influenza A/B Rapid Test (ROCHE Lab.).
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by Influenza A/B Rapid Test (Fig. 2), and also revealed co-infection
between influenza and the bacteria, Stenotrophomonas maltophilia.
Figure 1 shows the presence of influenza viruses and the flagellated
bacteria in the total samples collected. The Influenza A/B Rapid Test
results that confirmed the presence of influenza virus in samples from
pigs (No. 02, 03, 04, 05, 06) (Table 1) humans (No. 01, 03, 04, 05)
(Table 2) and equines (No. 01, 02, 03, 04) (Table 3) are clearly
demonstrated in Fig. 2. Figure 3 is an electron micrograph showing
the presence of both bacteria and influenza virus in infected samples.
Thus, microbiological tests demonstrated the presence of
Stenotrophomonas maltophilia, in human and animal samples, resistant
to the antibiotics streptomycin, penicillin and fungizone, but sensitive
to sulfadiazine. The casein agar test showed presence of the
Stenotrophomonas maltophilia protease, in those isolate samples, by
the halos of proteolytic activity that could be compared with halos of
the trypsin used as control (Fig. 4).
After treatment of the samples with sulfadiazine, the
Stenotrophomonas were inactivated and, in consequence of the protease
decrease, the intense CPE of the influenza virus was decreased in these
cultures, as well as the HA viral titers.
DISCUSSION
According to the results obtained in this work, with subjects from
three different localities of São Roque, SP, Brazil, during the influenza
season it was seen that 21.11% of the thirteen confirmed influenza
virus in samples isolated from animals, pigs, horses and from humans
(working as veterinarians or feeding the animals) from locations a and
c had been co-infected with Stenotrophomonas maltophilia. While in
location b the confirmed influenza samples exhibited no co-infection
with bacteria at the time of these experiments. No influenza (negatives)
was detected in the remaining 34/47 samples collected. Such co-
infection caused exacerbation of the influenza virus, in consequence
of the bacterial protease, elastase, by the cleavage and activation of
HA of these viruses which could be detected by the intense cytopathic
effect of the infected cell cultures.
Together with previously published data, this in vitro finding
suggests that co-infection can complicate the respiratory disease
syndrome during influenza virus infection in vivo18. Swine influenza
has been previously reported to be complicated by additional bacterial
pathogens18,22.
In this study, 5/5 pig influenza samples were co-infected with
bacteria. The equine samples were submitted to virus isolation, and 4/
11 were positive for influenza and 100% of these positive samples
were contaminated with the bacteria Stenotrophomonas maltophilia.
In the samples collected from twelve humans (animal feeders and
veterinarians) positivity to influenza virus was confirmed 41.63% (one
of which confirmed by the EM) and a similar exacerbation of the
infectivity in both cell cultures or in eggs was observed when bacterial
co-infection with Stenotrophomonas maltophilia was present.
Fig. 1 - Presence of the influenza viruses and Stenotrophomonas maltophilia in isolated
samples.
Fig. 2 - Influenza Rapid Test – GLORIA (Gold-Labeled-Optically-Read-Immunoassay).
Fig. 3 - Electron micrograph of the flagellated bacteria and influenza virus present in isolate
sample.
Fig. 4 - Casein Agar Test – Human, Equine and Pig Influenza samples co-infected with
Stenotrophomonas maltophilia.
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Comparing the beginning of the CPE of the virus in monolayers of
the MDCK and NCI cells, it was observed that CPE started in the 72 h
when these samples persisted with bacterial contamination, while the
others took a longer time of six to seven days for starting the CPE. The
Electron Microscopy technique also corroborated the confirmation of
positivity obtained by the tests used in this work.
The serological test confirmed in some samples from subjects
screened for influenza identification and characterization, is
demonstrated in Figure 2.
From these results demonstrating influenza and bacteria co-
infection, it may be concluded that the evaluated subjects (humans
and animals) were submitted to double transmissions occurring in the
two locations studied (a and c) situated in the São Roque region, SP,
Brazil. It should be taken into consideration that Stenotrophomonas
maltophilia is an opportunistic invader from environmental sources,
such as soil or water, and it is probable that this co-infection occurred
first among the animals and was then transmitted to the humans. In
addition, no subject showed clinical manifestations of the classical
Flu syndrome during the sample collection, as has also been reported
in other studies14,19.
Whether these asymptomatic subjects had clinical manifestations after
the oral swab collection times, this would be associated with the level of
the transmitted viral charge. It is important to underscore that even a
minimal viral charge can possibly increase its potential when in appropriate
conditions, as shown by the viral replication methods used here.
It is considered that the more hygienic conditions of the production
facilities at location b were responsible for the prevention of virus and
bacteria co-infection.
In this study, Stenotrophomonas maltophilia protease developed
the same role as trypsin, usually added to influenza virus inoculation
in cell culture. Such use aims to increase influenza infectivity, by
cleavage of HA of this virus, during its cultivation, as has been
demonstrated by the present authors in other work9.
In summary, it was concluded that co-infection can occur between
bacteria and influenza virus, thereby causing a potential risk to
susceptible hosts. Co-infection resulting in respiratory tropism of the
influenza virus, such as by Stenotrophomonas maltophilia protease,
represents a strong mutual help, facilitating either opportunist bacterial
invasion into the respiratory tract or exacerbation of the viral infection
through the cleavage activation of the HA influenza. This study may
contribute to future knowledge in this field. Further experiments,
however, should be performed to analyze direct inter-species
transmission of the influenza virus, in the form of zoonoses.
RESUMO
Co-infecção entre vírus influenza e bactéria flagelada
Tripsina é necessária na ativação da clivagem do vírus influenza A
in vitro. Esta clivagem é importante para entrada do vírus na célula por
endocitose mediada pelo receptor celular. Bactérias presentes no trato
respiratório são fontes de proteases que podem contribuir na replicação
do vírus influenza in vivo. Entre 47 amostras coletadas de cavalos, suí-
nos e humanos, a influenza foi isolada e confirmada em 13 que estavam
co-infectadas com bactéria flagelada: Stenotrophomonas maltophilia
desde o início destes experimentos. Apesar do tratamento das amostras
com antibióticos, as bactérias resistiram em diversas delas (48.39%). A
protease (elastase), secretada pela Stenotrophomonas maltophilia, de-
senvolveu papel decisivo na potencialização da infecção pelo vírus
influenza. Essa atividade proteolítica foi detectada pelo teste de ágar-
caseína. Amostras positivas para o vírus influenza isolado em animais,
bem como em humanos tiveram potencialização da infectividade (ECP)
em células MDCK e NCI-H292, sempre que a Stenotrophomonas
maltophilia esteve presente. Os referidos microorganismos, bactéria e
vírus foram observados ultra-estruturalmente. Esses achados in vitro
demonstram como complicações respiratórias podem ocorrer in vivo,
através da contribuição de protease microbiana, provocando aumento
da inflamação ou destruição dos inibidores celulares de proteases
endógenas, nos hospedeiros susceptíveis à influenza.
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